CARING BRANDS INC (CABR)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
QuarterlyIQ Insights · CABR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 551.1% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of —
CABR — capital allocation — Material Modification to Rights of Security Holders
Dated 2026-10-22
Material Modification to Rights of Security Holders. To the extent required by this Item 3.03, the information set forth in
Why it matters: The pro forma is above Nasdaq’s $2.5 million equity minimum. A later filing can show whether that cushion remains.
Worry ifA later report shows equity below $2.5 million, or Nasdaq says the company is out of compliance.
Less concerning ifA later report shows equity above $2.5 million, and Nasdaq says the company is in compliance.
Why it matters: The company reported only $419 of revenue in 2025-Q4. New license reach matters only if sales grow.
Supportive ifThe next filing reports product revenue above $740, the 2025-Q3 level. It names sales from licensees or direct sales.
Worry ifThe next filing reports revenue at or below $419, or gives no product revenue update.
Why it matters: The company said it was waiting for the funds after an initial $4.6 million closing. The final amount affects cash available for its plans.
Supportive ifA filing confirms the remaining $4.4 million cleared. It also confirms the related preferred shares and warrants were issued.
Worry ifA filing reports the $4.4 million did not clear, was reduced, or the closing did not occur.
Why it matters: The company remains loss-making, and the supplied pro forma lists a $256,861 July-August operating loss. A lower loss would show progress.
Supportive ifThe Nov. 13 report shows an operating loss below $256,861 for a matching two-month period, or reports an operating profit.
Worry ifThe report shows an operating loss above $256,861 for a matching two-month period.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$316 on $10,000 · ±3.2% | How much price usually moves either way. |
| Bad day | $1,152 loss on $10,000 · 11.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,380 loss on $10,000 · 83.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.